Literature DB >> 26585152

Estradiol-Induced Transcriptional Regulation of Long Non-Coding RNA, HOTAIR.

Arunoday Bhan1, Subhrangsu S Mandal2.   

Abstract

HOTAIR (HOX antisense intergenic RNA) is a 2.2 kb long non-coding RNA (lncRNA), transcribed from the antisense strand of homeobox C (HOXC) gene locus in chromosome 12. HOTAIR acts as a scaffolding lncRNA. It interacts and guides various chromatin-modifying complexes such as PRC2 (polycomb-repressive complex 2) and LSD1 (lysine-specific demethylase 1) to the target gene promoters leading to their gene silencing. Various studies have demonstrated that HOTAIR overexpression is associated with breast cancer. Recent studies from our laboratory demonstrate that HOTAIR is required for viability of breast cancer cells and is transcriptionally regulated by estradiol (E2) in vitro and in vivo. This chapter describes protocols for analysis of the HOTAIR promoter, cloning, transfection and dual luciferase assays, knockdown of protein synthesis by antisense oligonucleotides, and chromatin immunoprecipitation (ChIP) assay. These protocols are useful for studying the estrogen-mediated transcriptional regulation of lncRNA HOTAIR, as well as other protein coding genes and non-coding RNAs.

Entities:  

Keywords:  Epigenetics; Estradiol; Estrogen receptor s; Gene expression; HOTAIR; Long non-coding RNA; Mixed lineage leukemia; Polycomb-repressive complex 2

Mesh:

Substances:

Year:  2016        PMID: 26585152     DOI: 10.1007/978-1-4939-3127-9_31

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Emerging roles of long non-coding RNAs in cancer.

Authors:  Manjima Chatterjee; Sonali Sengupta
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 2.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

3.  linc00673 (ERRLR01) is a prognostic indicator of overall survival in breast cancer.

Authors:  Ubaidat Abdul-Rahman; Balázs Győrffy; Brian D Adams
Journal:  Transcription       Date:  2017-10-04

4.  Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma.

Authors:  Seungkyung Kang; Miree Park; Jung Yeon Cho; Su Jin Ahn; Changhwan Yoon; Sang Gyun Kim; Soo-Jeong Cho
Journal:  Gastric Cancer       Date:  2022-04-07       Impact factor: 7.701

5.  ESR1-Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression.

Authors:  Yuichi Mitobe; Kazuhiro Ikeda; Takashi Suzuki; Kiyoshi Takagi; Hidetaka Kawabata; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Mol Cell Biol       Date:  2019-11-12       Impact factor: 4.272

Review 6.  Current Status of Long Non-Coding RNAs in Human Breast Cancer.

Authors:  Stefanie Cerk; Daniela Schwarzenbacher; Jan Basri Adiprasito; Michael Stotz; Georg C Hutterer; Armin Gerger; Hui Ling; George Adrian Calin; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-09-06       Impact factor: 5.923

Review 7.  Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.

Authors:  Fredy O Beltrán-Anaya; Alberto Cedro-Tanda; Alfredo Hidalgo-Miranda; Sandra L Romero-Cordoba
Journal:  Front Physiol       Date:  2016-08-08       Impact factor: 4.566

8.  HOTAIR Long Non-coding RNA: Characterizing the Locus Features by the In Silico Approaches.

Authors:  Mohammadreza Hajjari; Saghar Rahnama
Journal:  Genomics Inform       Date:  2017-12-29

9.  The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells.

Authors:  Hsin-Chen Lin; Ching-Ching Yeh; Lo-Yun Chao; Mong-Hsun Tsai; Hung-Hsin Chen; Eric Y Chuang; Liang-Chuan Lai
Journal:  Oncotarget       Date:  2017-12-28

Review 10.  Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review).

Authors:  Cheng Wei; Liangjuan Zhao; Hao Liang; Yingwei Zhen; Lei Han
Journal:  Oncol Rep       Date:  2020-03-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.